Skip to main content
Clinical Trials/NCT05849818
NCT05849818
Recruiting
Not Applicable

Virtual Reality Technology For Cognitive Functions Of Children With Down Syndrome

Cairo University1 site in 1 country30 target enrollmentMay 2023
ConditionsDown Syndrome

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Down Syndrome
Sponsor
Cairo University
Enrollment
30
Locations
1
Primary Endpoint
Rate of change of cognitive function by using the rehacom device
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the study is to identify the effect of fully-immersive virtual reality technology on cognitive functions of children with Down syndrome

Detailed Description

Intellectual disability is recognized as one of the most prominent features of DS which is the most common genetic cause of intellectual disability. Cognitive functioning often changes across the lifespan and is moderated by several comorbid factors such as sensory impairments, seizures, autism, sleep disruption, and other medical and psychiatric conditions (Grieco et al., 2015). There is encouraging evidence supporting the use of non-immersive virtual environments to provide useful learning, rehabilitation, and leisure experiences for people with intellectual disabilities. Therefore, immersive VR applications may also be an effective way to improve motivation and engagement for children with DS in learning settings (Michalski et al., 2022). Therefore, this study aims to investigate the effect of full-immersive VRapeutic software gaming technology on cognitive functions of children with Down syndrome

Registry
clinicaltrials.gov
Start Date
May 2023
End Date
August 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ayman Kamal Elboraey

Professor of Pediatric physical therapy

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with Down Syndrome Age from 6-10 years Both Genders will be included IQ Ranges from 50-69(mild intellectual disability) they will be able to understand the instructions able to walk independently

Exclusion Criteria

  • Significant Visual or Hearing problems Significant mental or psychological problems that interfere with understanding instructions musculoskeletal problems or fixed deformities in upper or lower limbs Current hospitalization for urgent Medical reasons

Outcomes

Primary Outcomes

Rate of change of cognitive function by using the rehacom device

Time Frame: up to two months

Assessing the change of the cognitive function By using the Rehacom Device within two months

Study Sites (1)

Loading locations...

Similar Trials